If you get away with that, you would actually be a disrupter, except not a particularly nice one.
Currently the most successful people doing that are child psychiatrists and big pharma, but they convince the parents to buy the drugs for the kids instead. Government seems to be fine with this though, as well as most of society.
You can get the basically same report running Promethease on 23andMe data dump. There is a website even providing automatic 23andMe data import using 23andMe's API.
You can run the raw data through a 3rd party tool like Promethease (http://snpedia.com/index.php/Promethease) while you wait for the FDA kerfuffle to work itself out. YMMV though.
Since they're still going to provide the data to new users, I wonder if some of their interpretations could be recreated and published by existing users who still have access to the interpretations.
Yes, for the mendelian ones that can be inferred in a relatively straightforward way from the raw data. Not really, for the more complicated risk assessments.
Their interpretations were based on poorly proven associations between genes and disease-outcomes. I bet with the info you could look up on wikipedia/google scholar much of what you needed to know. But it depends on the format of this data dump.
All well and good that intervals of confidence exist in medical research. But good understandings of these associations have been reached with very few genes. The categories alone do not prove that they apply broadly enough to justify the product.
I think it's likely that the new Thunderbolt display will be the exact same 23.8" panel, but with updated Thunderbolt expansion hardware (USB 3.0, &c.)
A theory is that Apple is being a large consumer of this display panel. This leads to more of these display panels being produced which leads to a lower price. It seems odd that the other sizes (24 and 32) are much more expensive than this 28.